Article
Aceruloplasminaemia: a family with a novel mutation and long-term therapy with deferasirox.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme - 1 Apr 2015
Lindner U, Schuppan D, Schleithoff L, Habeck J-O, Grodde T, Kirchhof K, Stoelzel U
Abstract excerpt
Ceruloplasmin is a member of the multicopper oxidase family that plays a major role in the transport of iron in the body. Aceruloplasminaemia (ACP) is a rare disease and is clinically identified by iron overload in liver, pancreas, brain, and other organs, and by microcytic anaemia. So far, the iron chelator deferasirox was given for therapy only up to 6 months due to side effects. Here, we describe a novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.